CurrentEndo
Get Weekly

Topic · page 85 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,361–3,400 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    First‐in‐human study of CPL207280 , a novel G‐protein‐coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration

    Cohort study

  2. Diabetes Care

    Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial

    Secondary analysis

  3. Diabetes Care

    Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

    Cohort study

  4. Diabetes Metab

    Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020

    Cohort study

  5. Diabetes Obes Metab

    Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial

    Secondary analysis

  6. Diabetes Care

    Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

    Secondary analysis

  7. Cardiovasc Diabetol

    Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database

    Cohort study

  8. Diabetes Obes Metab

    Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials

    Meta-analysis

  9. Diabetes Care

    Impact of Glucose-Lowering Medications on Health-Related Quality of Life in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

    Secondary analysis

  10. Diabetes Care

    Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy

    Secondary analysis

  11. Diabetes Obes Metab

    Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease

    Cohort study

  12. Diabetes Obes Metab

    Twenty‐four‐hour physical behaviour profiles across type 2 diabetes mellitus subtypes

    Cross-sectional study

  13. J Clin Endocrinol Metab

    Associations Between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis

    Cohort study

  14. BMJ Open Diabetes Res Care

    Should insulin resistance (HOMA-IR), insulin secretion (HOMA-β), and visceral fat area be considered for improving the performance of diabetes risk prediction models

    Cohort study

  15. Cardiovasc Diabetol

    Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population

    Cohort study

  16. Cardiovasc Diabetol

    Evaluation of the role of atherogenic index of plasma in the reversion from Prediabetes to normoglycemia or progression to Diabetes: a multi-center retrospective cohort study

    Cohort study

  17. Cardiovasc Diabetol

    Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study

    Cohort study

  18. Cardiovasc Diabetol

    The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

    Randomized controlled trial

  19. Cardiovasc Diabetol

    GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes

    Cohort study

  20. Cardiovasc Diabetol

    Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients

    Case-control study

  21. Cardiovasc Diabetol

    Nonlinear relationship between untraditional lipid parameters and the risk of prediabetes: a large retrospective study based on Chinese adults

    Cross-sectional study

  22. Cardiovasc Diabetol

    Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events in patients undergoing complex coronary artery intervention: a large-scale cohort study

    Cohort study

  23. Diabetes Care

    Leisure-Time Physical Activity May Attenuate the Impact of Diabetes on Cognitive Decline in Middle-Aged and Older Adults: Findings From the ELSA-Brasil Study

    Cohort study

  24. Diabetes Care

    Modifiable Lifestyle Factors, Genetic Risk, and Incident Peripheral Artery Disease Among Individuals With Type 2 Diabetes: A Prospective Study

    Cohort study

  25. Diabetes Care

    Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

    Secondary analysis

  26. Diabetes Technol Ther

    The Role of a “Technology Navigator” in an Academic Diabetes Clinic: A Feasibility Evaluation

    Research article

  27. Diabetologia

    Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

    Meta-analysis

  28. J Clin Endocrinol Metab

    Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes

    Cohort study

  29. Diabetes Obes Metab

    Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials

    Secondary analysis

  30. Diabetes Care

    Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes

    Case-control study

  31. Cardiovasc Diabetol

    Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke

    Cohort study

  32. J Clin Endocrinol Metab

    Association Between Plasma LRG1 and Lower Cognitive Function in Asians With Type 2 Diabetes Mellitus

    Cohort study

  33. Cardiovasc Diabetol

    Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes

    Cohort study

  34. Cardiovasc Diabetol

    Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

    Meta-analysis

  35. Cardiovasc Diabetol

    Association of long-term triglyceride-glucose index patterns with the incidence of chronic kidney disease among non-diabetic population: evidence from a functional community cohort

    Cohort study

  36. Diabetes Technol Ther

    A Minimized Measurement Scheme for Predicting HbA1c Using Discrete Self-Monitoring Blood Glucose Data Within 4 Weeks for People with Type 2 Diabetes

    Research article

  37. Diabetes Care

    Risk Assessment for Gastrointestinal Diseases via Clinical Dimension and Genome-Wide Polygenic Risk Scores of Type 2 Diabetes: A Population-Based Cohort Study

    Cohort study

  38. J Clin Endocrinol Metab

    Orthostatic Hypotension Promotes the Progression From Mild Cognitive Impairment to Dementia in Type 2 Diabetes Mellitus

    Cohort study

  39. Diabetes Obes Metab

    Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada

    Cohort study

  40. JAMA Netw Open

    Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 3,361–3,400 of 4,758, newest first